Genentech’s Investigational Personalized Medicine Entrectinib Shrank Tumors in People With NTRK Fusion-Positive Solid Tumors 10/23/2018 Medications, South San Francisco, CA -- October 21, 2018 -- Genentech, a member of the Roche...